Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions

Koki Nakanishi1, Zhezhen Jin2, Shunichi Homma1

  • 1Department of Medicine, Columbia University, New York, NY.

Insights

Left ventricular hypertrophy, both concentric and eccentric, is linked to silent cerebrovascular disease. These heart conditions increase stroke risk, especially in certain demographics.

Area of Science:

  • Cardiology
  • Neurology
  • Radiology

Background:

  • Abnormal left ventricular (LV) geometric patterns are known prognostic indicators for morbidity and mortality.
  • The association between LV geometric patterns and silent cerebrovascular disease (SCVD) remains underexplored.

Purpose of the Study:

  • To investigate the relationship between different left ventricular geometric patterns and the presence of subclinical cerebrovascular disease.
  • To determine if specific LV geometric patterns are associated with silent brain infarcts (SBIs) and white matter hyperintensity volume (WMHV).

Main Methods:

  • A cohort of 665 participants from the CABL study underwent echocardiography and brain MRI.
  • Participants were categorized into four LV geometric patterns: normal, concentric remodeling, eccentric hypertrophy, and concentric hypertrophy.
  • SCVD was assessed by the presence of SBIs and the volume of WMHV.

Main Results:

  • Concentric hypertrophy showed the highest risk for both SBIs (aOR 3.39) and WMHV (aOR 3.35).
  • Eccentric hypertrophy also demonstrated significant associations with SBIs (aOR 2.52) and WMHV (aOR 1.96).
  • Concentric remodeling was not associated with SCVD. Associations varied across sex, age, and race-ethnic subgroups.

Conclusions:

  • Left ventricular hypertrophy, encompassing both eccentric and concentric patterns, is significantly associated with subclinical cerebrovascular disease in a general, stroke-free population.
  • LV geometric patterns may confer differential risks for SCVD depending on demographic factors such as sex, age, race-ethnicity, and body size.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
371
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
786
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
718
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
666